Associated Banc Corp Iovance Biotherapeutics, Inc. Transaction History

Associated Banc Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$28.67 - $52.59 $917 - $1,682	-32 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$27.75 - $36.3 $333 - $435	-12 Reduced 27.27%	32 $1,000
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $81 - $123	-3 Reduced 6.38%	44 $1,000
Q1 2020 May 14, 2020	BUY	$19.54 - $38.85 $918 - $1,825	47 New	47 $1,000

319

238M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.71B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

Stay updated on Associated Banc Corp with notifications on news.